Second Sight to Present at RBC Capital Markets 2016 Global Healthcare Conference and Host Meetings at 2016 BTIG MedTech Conference

SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (“Second Sight” or “the Company”) (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Dr. Robert Greenberg, Chairman, and Will McGuire, President and Chief Executive Officer, will host one-on-one meetings and present at the following conferences this month:     Conference: RBC Capital Markets 2016 Global Healthcare Confere


AXINESIS REAplan Upper Limb Rehab Robotic System Cleared in EU

AXINESIS,  startup out of Université catholique de Louvain, Belgium, won the European CE Mark to introduce its REAplan arm rehabilitation system. The product is designed to help people with brain injury, such as a stroke, recover motor activity in the upper limbs. The robotic device runs the patient through repetitive movement game (Read more...)

Speaker: Venture capital drives innovation in medical retina research

MIAMI — Robust investment by venture capitalists is making up for stagnant government funding for medical research, particularly in the ophthalmic and biotechnology sectors, a speaker told colleagues here.“Necessity is the mother invention. I like to say that prosperity is the father of innovation. We can’t have innovation unless we have a robust economy because we need that money to drive the innovation,” Emmett T. Cunningham Jr., MD, PhD, MPH, said at Angiogenesis, Exudation, and Degeneration 2016.